scorecardresearchAspira Pathlab & Diagnostics Share Price Live NSE, BSE, Today - Aspira
Mintgenie
Asian Paints2,835.00-32.30 (-1.13%)
Axis Bank1,112.0048.30 (4.54%)
Bajaj Finance7,210.00-117.70 (-1.61%)
Bajaj Finserv1,621.60-8.85 (-0.54%)
Bharti Airtel1,333.20-3.05 (-0.23%)
HCL Technologies1,491.2011.55 (0.78%)
HDFC Bank1,510.30-0.65 (-0.04%)
Hindustan Unilever2,219.10-40.05 (-1.77%)
ICICI Bank1,103.907.05 (0.64%)
ITC430.902.05 (0.48%)
Indusind Bank1,476.301.65 (0.11%)
Infosys1,430.00-1.85 (-0.13%)
Kotak Mahindra Bank1,657.85-185.20 (-10.05%)
Larsen & Toubro3,625.75-9.20 (-0.25%)
Mahindra & Mahindra2,070.7011.45 (0.56%)
Maruti Suzuki India12,738.15-201.80 (-1.56%)
NTPC351.35-0.20 (-0.06%)
Nestle India2,510.057.15 (0.29%)
Power Grid Corporation Of India290.40-0.15 (-0.05%)
Reliance Industries2,901.651.05 (0.04%)
State Bank Of India781.308.10 (1.05%)
Sun Pharmaceutical Industries1,500.5514.20 (0.96%)
Tata Consultancy Services3,839.708.45 (0.22%)
Tata Motors991.55-0.05 (-0.01%)
Tata Steel164.25-1.25 (-0.76%)
Tech Mahindra1,178.70-7.40 (-0.62%)
Titan Company3,577.00-30.55 (-0.85%)
Ultratech Cement9,605.45-52.40 (-0.54%)
Wipro458.95-1.25 (-0.27%)

Aspira Pathlab & Diagnostics

BSE: 540788 | NSE: | ISIN: INE500C01017 | SECTOR: Healthcare Facilities

₹31.99 1.19 (3.86%)

25 Apr 2024, 05:15 (IST)

  • Open

    31.99

  • High

    31.99

  • Low

    31.99

  • Prev Close

    30.80

  • P/E

    -

  • Median P/E

    -

  • P/B

    -

  • Median P/B

    -

  • Market Cap

    0.33B

  • Volume

    1.09K

  • Vol. (20 day Avg.)

    0

  • PEG

    -

  • Div.Yield

    -

  • Bid

    30.10

  • Ask

    32.39
View all metrics

Company Description

  • Healthcare Facilities

  • BSE

    540788

  • NSE

  • ISIN

    INE500C01017

Aspira Pathlab & Diagnostics Limited is an India-based company, which is engaged in the business of running, owning, managing, and administering Diagnostics Centers. The principal activities of the Company consist of pathology investigation services, radiology investigation services and other related healthcare services at diagnostic centers in Mumbai. The Company carries out pathological investigations in various branches, including biochemistry, hematology, histopathology, microbiology, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. The Company's tests include COVID-19 tests, health packages and pathology tests. Its COVID-19 tests include Shanti Screening Test, COVID-19 Antibody Test, COVID-19 Surveillance Profile, COVID-19 RT-PCR Test, COVID-19 Detection Profile 1, and COVID-19 Detection Profile 2.

Company Officers

    No data available